P-288 Azacitidine therapy in high-risk myelodysplastic syndromes (MDS): A single centre experience

2013 ◽  
Vol 37 ◽  
pp. S152
Author(s):  
S. Improta ◽  
A. Gagliardi ◽  
M.R. Villa ◽  
P. Della Cioppa ◽  
M. Esposito ◽  
...  
2008 ◽  
Vol 17 ◽  
pp. S181
Author(s):  
Sze-Yuan Ooi ◽  
Mark Pitney ◽  
Joseph Matthews ◽  
Robert Giles ◽  
Daniel Friedman ◽  
...  

2021 ◽  
Vol 108 (Supplement_7) ◽  
Author(s):  
M A Gok ◽  
O Shams ◽  
F Ftaieh ◽  
U A Khan

Abstract Aims National emergency laparotomy audit (NELA) developed in 2014 in the UK, aims to improve of quality of care of patients undergoing emergency laparotomy. NELA highlights the importance of identifying high risk patients for potential significant morbidity and mortality. The aim of this study is to review the NELA 30 day mortality at a single centre. Methods This is a retrospective review of all 30 day NELA mortality patients since 2014 carried out at East Cheshire NHS Trust until January 2020. The NELA survivors beyond 30 days were used as controls. Results Conclusion The overall NELA 30 day mortality rate was 9.8 %. NELA deaths occurred in the older, frail, multi-comorbid & high ASA status patients. Most NELA deaths occur within 90 days, whereas patient survival curve appears to plateau out beyond 90 days. P possum can be used to identify high risk patients, where early collaborative senior assessment by consultant surgeons, anaesthetists and intensivists may identify and allocate appropriate surgical intervention. 


Sign in / Sign up

Export Citation Format

Share Document